Fundz

Conexeu Sciences reported raising $1.5 Million in an initial SEC Form D filing, from an offering of $3 Million

PUBLIC · CNXUOct 21, 2026

Amount Raised

$1.5 Million

$1.5 Million sold, per SEC Form D (first sale Oct 15, 2026)

Round Type

Venture

RenoBiotechnology

Who to call at Conexeu Sciences, and when

A new round usually means Conexeu Sciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Conexeu Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Conexeu Sciences, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Conexeu Sciences

Location

Reno, Nevada, United States

About

Conexeu Sciences is a biotechnology company advancing regenerative medicine with its patented collagen flowable gel platform. Emerging from over a decade of University research, Conexeu is developing this groundbreaking technology that could transform wound care, medical aesthetics, and tissue engineering. The company holds patents in the U.S., E.U., Japan, Australia, and pending in Canada, underscoring its global leadership in this innovation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Conexeu Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDavid B., Director, Founder hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Conexeu Sciences's next move

See what Strategic adds

Conexeu Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.